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Abstract: Tuberculosis (ТВ) is the main bacterial pathogen that causes more deaths than 
AIDS, malaria and all infectious diseases. The unusual long doubling time (about 24h), highly 
hydrophobic cell envelope resistant to chemical lysis was the reason to delay the molecular 
study of this bacteria. Fifteen years ago, we did not have any molecular tools and methods for 
genetic manipulation or isolation and analysis of intracellular protein and nucleic acids. Today  
we have many useful shuttle or integration vectors for basic study of mycobacteria. The full 
sequence of M. tuberculosis genome is already known. At the present time the diagnosis of  
tuberculosis is supported with fast-culture system BACTEC and molecular techniques based 
on PCR and D NA hybridization. The mechanisms of resistance to antituberculosis drugs were 
described, and first identification of resistance profile is available by using PCR and 
sequencing or real time PCR methods. In our group in the Center for Microbiology and 
Virology Polish Academy of Sciences and in the Dept, of Genetics of Microorganisms, 
University Łódź we have characterized new insertion sequences from M. tuberculosis complex- 
18990 and IS1607. In diagnostic studies we have proposed the DIG-PCR ELISA assay as 
a reliable, specific and sensitive test to identify M. tuberculosis directly in clinical samples. 
We have performed wide epidemiological studies of M. tuberculosis strains isolated from Polish 
ТВ patients including drug -  and multidrug -  resistant strains. Finally we identified the most 
frequently present mutations responsible for drug resistance of polish clinical isolates of  
M. tuberculosis.
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1. Introduction
Tuberculosis (TB) is caused by Mycobacterium tuberculosis, Mycobacterium 
africanum, Mycobacterium bovis, Mycobacterium microti, Mycobacterium 
canetti and is a persistent problem in the developing world. The World 
Health Organization estimates that approximately one-third of the world’s 
population is infected with tuberculosis and in this decade alone, almost 
90 million people will contact tuberculosis (Ko c h i  1999). During the same 
time period, approximately 3 million people die annually from this disease, 
resulting in more deaths than are caused by any other single pathogen 
(CDC, 1999).
M. tuberculosis has posed a formidable challenge to biomedical researchers 
as a result of its long generation time, fastidious growth requirements, and 
high risk of contagion. In the last decade, the development of efficient 
vectors and allelic exchange system has rendered the tubercle bacillus more 
amenable to molecular genetic analysis and this has greatly facilitated 
studies of its biochemistry, physiology, and pathogenicity (Ba r a d o v  et al. 
1997; Pe l i c i c  et al. 1997). The availability of the complete genome 
sequence and its detailed bioinformatics analysis has provided us with 
a wealth of new information, knowledge, and understanding of the biology 
of this major human pathogen (Co l e  et al. 1998).
2. Mycobacterium tuberculosis Insertion Sequences
The only DNA mobile elements of M. tuberculosis (excluding bacteriop-
hages) are insertion sequences. The best-known insertion sequence of 
M. tuberculosis is IS6110, insertion element present in different number of 
copies in various loci in the genomes of species belonging to the 
M. tuberculosis complex (KENT et al. 1995; MCHUGH et al. 1997). However, 
it was reported that some M. tuberculosis strains exist that do not posses 
the IS6110 insertion sequence in their genomes (SAJDUDA et al. 1998). The 
IS 6 //0  insertion sequence has previously been reported to be specific for 
the M. tuberculosis complex, but IS6770-like sequences are present in 
MOTT (SJÖBRING et al. 1990). This multicopy element is widely used both 
for epidemiological and diagnostic studies. The first mycobacterial insertion 
sequence was discovered in 1987, until today 46 lS-like elements are known. 
The sequencing of M. tuberculosis genome revealed 25 new IS-like sequences. 
Of the 46 mycobacterial ISs described, only 6 have been shown to be active 
and able to transpose from one site on a DNA molecule to another. Most 
of these 46 ISs are restricted to very limited host range, making them
a good tool for the molecular typing of mycobacteria (e.g. 1S990, IS 1081, 
and IS 1607).
We have characterized a new insertion sequence from M. tuberculosis, it is 
a member of the IS3 family and is related to IS6//0 (Fig. I) ( D z i a d e k  et al. 
1998). A characteristic of these elements is the involvement of ribosomal frame 
shifting in the generation of functional transposase by fusion of the ORFa and 
ORFb polypeptides. The two ORFs in IS990 have been shown to display 
significant homology to IS3 ORFa and ORFb sequences. The potential frame 
shift region overlaps exactly with the same region of the IS6110 element. The 
nucleotide homology of the region including 30 nucleotides overlap between 
IS6110 and IS990 is 70%. In contrast to IS6110, IS990 is present as only 
a single copy in all strains of M. tuberculosis -  complex that have been tested 
so far. Mycobacterium bovis, Mycobacterium bovis BCG, M. microti and 
M. africanum strains revealed the presence of IS990 insertion sequence by 
hybridization and PCR-based analysis. To determine the host range of IS990, 
the chromosomal DNA from different species of mycobacteria was extracted 
and analyzed by Southern hybridization using fragment of IS99Ö as the probe. 
Fourteen different strains of Mycobacterium avium, two M. simiae strains, two 
M. lufu strains, two M. malmoense strains, M. intracellularae, M. gordonae, 
M.fortuitum, M. scrofulaceum and M. paratuberculosis were tested. None of 
these showed hybridization signal when used with the investigated probe 
(Fig. 2). These data were confirmed by PCR- based analysis (the expected 
amplification product was observed only in the case of Mycobacterium 
tuberculosis complex bacteria). By the end of 2000, 350 clinical isolates of 
M. tuberculosis have been examined; all M. tuberculosis strains contain IS990 
DNA. The presence of IS990 as a single copy element in M. tuberculosis 
strains strongly suggests its possible application in diagnosis of M. tuberculosis 
infections.
ORF a ORF b
tgaccgctttccgccg cgggtgcacgcgałca
Fig. 1. The composition of IS990 belonging to the IS3 family. IS990 is bordered by 16 bp 
inverted repeals (IRs). The ribosome slippage region is marked with RS. The mutations in 
ORFb are indicated by Xs. Primers used for amplification of 1S990 fragments are shown as 
arrows and designated as 49 A-E. The nucleotide positions of the start and end of 1S990 are
correlated with Y49 cosmid
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Fig. 2. The species -  specificity analysis of 1S990 by Southern hybridisation with Pvul [-digested 
DNAs from different mycobacterial species. M. bovis BCG (3-4), M. bo vis (5-6), M. scrofulaceum 
(7), M. fortuitum (8), M. gordonae (9), M. malmoense (10-11), M. lufu (12-13), M. simiae 
like A (14), M. simiae like В (15), M. intracellulare  (16), M. avium (17). Lane 1 represents 
the molecular mass marker (bacteriophage Я D N A  restricted by HindiII) and lane 2 was 
loaded with the D N A  o f M. tuberculosis 370 (positive control)
We also described insertion sequence IS 1607 -  a new M. tuberculosis 
complex sequence -  related element ( D z i a d e k  et al. 2000). IS1607 was 
also present as a single copy in M. tuberculosis, M. bovis, and M. bovis 
BCG strains. This sequence existed in M. africanum and M. microti, but 
was not present in 69 strains of 19 atypical mycobacterial species analy-
zed by using polymerase chain reaction (PCR) or Southern hybridization 
assay.
2.1. PCR-based diagnosis of tuberculosis
This observation concerning the presence of IS990 and IS1607 in 
M. tuberculosis strains, strongly suggest possible application of these sequences 
in PCR-based diagnosis of tuberculosis.
Bacteriological diagnosis of mycobacterial infections remains a major 
problem and there is an urgent need for rapid and reliable diagnostic tests. 
Culturing of organisms has specificity that approaches 100% and permits 
susceptibility testing of the isolates, but the slow growth of most pathogenic 
mycobacteria (4 to 6 weeks) results in delays in diagnosis (SJÖBR1NG et al. 
1990; S h a w  AR et al. 1993). Identification of acid-fast bacilli stained smears 
may provide rapid diagnosis, but this method does not allow identification 
at the species level and requires a relatively large number of bacteria (>  104
cells/ml) present in a sample (K o lk  et al. 1992). Serological techniques 
may be useful in some clinical settings, but this approach is limited 
generally due to poor sensitivity and/or specificity. The DNA or RNA 
hybridization tests with labeled specific probes are not sensitive enough 
to be used for clinical specimens without prior culturing. The lack of 
simple, rapid, and reliable tests that can specifically detect M. tuber-
culosis in clinical specimens poses enormous problems for both individual 
patient management and implementation of appropriate infection control 
and public health measures. In the last decade PCR has set to be a use-
ful tool for the direct identification of mycobacteria in either cultured 
strains or uncultured clinical samples. PCR tests have been developed 
for diagnosis of tuberculosis (N o lte  et al. 1993). Commercially available 
tests are however too expensive for regular use in many regions where 
ТВ is most common. “In-house” PCR-based tests have been developed, 
many of which utilize mycobacterial insertion sequence IS6110 as target 
for the PCR (HUANG et al. 1996). However, IS6110 is not ideal as 
a target, since its copy number is variable and strains of M. tuberculosis 
have been identified that do not contain IS6110 (M cFadden , S ajdu da 
1996; S ajd ud a et al. 1998). Therefore, we have developed PCR-ELISA 
test that utilizes another M. tuberculosis-complex specific insertion se-
quence, IS990, as target (BORUŃ et al. 2001). We aimed to develop 
a simple and sensitive test that would be applicable in most clinical 
laboratories. We for that reason developed a simple preparation tech-
nique, followed by DNA amplification and detection of PCR product 
by capture plate hybridization and enzyme-linked immunoassay. We have 
used the M. tuberculosis -  complex insertion sequence IS990 as target 
and compared results with a similar PCR, which utilizes IS6110 as target 
(T h ie rry  et al. 1990; D ziad ek  et al. 1998). False-positive reactions 
that may be caused by previous amplicon contamination were prevented 
by the use of uracil-N-glycosylase and dUTP instead of dTTP (LONGO 
et al. 1990). The simplicity, sensitivity and specificity of this assay makes 
it a practical and affordable diagnostic test for detecting M. tuberculosis 
directly in clinical specimens in laboratories dealing with ТВ.
In this assay, digoxigenin (DIG) is incorporated into the PCR product, 
which is captured onto a streptavidin-coated microtiter well plate by DNA 
hybridization with a biotinylated capture probe. The captured amplicon is 
subsequently detected with an enzyme-conjugated antibody against DIG 
and a chromogenie substrate and is quantitated with an ELISA plate reader 
(Fig. 3). The sensitivity of DIG-PCR ELISA was determined by using 
serially diluted M. tuberculosis Mtl4323 genomic DNA and then detection 
by using this test. The ELISA could detect 5 fg of genomic DNA, an
DIG-PCR E l i s a
I ] : h  i i n  i i I
м . м м м Т Т Г
й п # ш г





t tm M -r r r
.
H ü
Unspecific q  , 
PCR product *
t tn rh łr r r r  J
! FT
_ M ____ Li-------faL .
^  w
% P r r  







Т Т Г Primer H I ' i  Biotinylated 
capture probe
Streptavidine DIG-UTP Anti DIG Ab
' POD-conjugated
Fig. 3. DIG-PCR ELISA assay, see text for description
equivalent to approximately one mycobacterial genome. Thus, the ELISA 
system was shown to be at least twice more sensitive than electrophoresis 
through a polyacrylamide gel and then ethidium bromide staining of PCR 
products. Two hundred sixty five clinical samples obtained from patients 
with confirmed and suspected tuberculosis during 1997-1999 were analyzed 
by DIG-PCR ELISA (Fig. 4). These specimens were tested in parallel by 
conventional culture on Löwenstein-Jensen slants, a radiometric culture 
system (BACTEC), and DIG-PCR ELISA. For 255 samples a complete 
agreement between the results of all three M. tuberculosis detection methods 
was observed. 123 samples were positive (culture, BACTEC and DIG-PCR 
ELISA positive) and 132 were negative. Six of the remaining ten samples 
(4 sputa, 1 bronchoalveolar lavage and 1 stomach lavage) did not produce 
an in vitro culture (those samples were smear negative, and BACTEC 
negative) but were found to be positive for M. tuberculosis DNA in 
DIG-PCR ELISA. Four samples (2 sputa, 1 bronchoalveolar lavage and 
1 urine) were culture and BACTEC positive (two samples were smear 
positive, and two were smear negative) but negative in DIG-PCR ELISA. 
To account for the anomalous results the clinical histories of the patients 
were reviewed. Six specimens that were culture -  negative but PCR
-  positive were from patients who had clinical manifestation of ТВ or were 
suspected of having a ТВ reactivation and were under antituberculosis
therapy. It was previously reported that the specimens could remain PCR 
positive for several weeks after the initiation of effective treatment and 
after the time that cultures become negative ( H e r r e r a ,  S e g o v i a  1996). 
Four PCR -  negative but culture positive specimens were found. A possible 
explanation could be the presence of inhibitory substances in these materials 
(2 sputa, 1 bronchoalveolar lavage, and 1 urine), that were not entirely 
removed by the purification process (we tested these materials for inhibition 
using M. tuberculosis Mtl4232 DNA as a template (100 ng DNA) -  for
1 sputa and 1 urine PCR was also negative), or lack of sensitivity of the 
PCR compared to culture.
Clinical Samples Category
Fig. 4. Results o f D1G-PCR ELISA detection of mycobacterial D N A  in various clinical 
samples using IS990. The horizontal bar at an absorbance of 0.34 represents the minimum  
cutoff value for the designation of a positive result. Clinical samples categories: 1 -  sputum; 
2 -  bronchoalveolar lavage; 3 -  urine; 4 -  pleural fluid; 5 -  larynx swab; 6 -  bronchial 
catheter; 7 -  stomach lavage; 8 -  cerebrospinal fluid; 9 -  known negative controls (sputum);
10 -  known negative controls (urine)
On the basis of these results the sensitivity of the test was found to be 
96.5%, and the specificity was 95.3% for both IS61J0 and IS990 -  targeted 
assays.
2.2. Epidemiological studies of Mycobacterium tuberculosis by restriction 
fragment length polymorphism (RFLP) analysis based on IS6110
The analysis of tuberculosis transmission and the tracing of the sources of 
infection require the ability to discriminate among M. tuberculosis strains. 
Several methods have been used for typing these strains. Until recently, all the 
methods relied on the study of phenotypic traits, such as serotype, biotype, 
bacteriophages sensitivity, or sensitivity to antimicrobial agents. These techniqu-
es have intrinsic limitations. For example, phenotypic expression may vary with 
culture conditions, and there are only a small number of phage types. To 
overcome these difficulties, genetic markers for the identification of strains 
within M. tuberculosis complex have been described. Insertion sequence IS6110 
has proved to be the most useful marker for epidemiological studies. Restric-
tion fragment length polymorphism (RFLP) analysis based on IS6110 has been 
useful for identifying transmission during outbreaks, for distinguishing between 
new infection and reactivation in patients who relapsed after treatment, and 
for the demonstration of cross-contamination of cultures in laboratories. 
Furthermore, an internationally accepted consensus for the standardized use of 
IS6110 has been established ( v a n  S o o l i n g e n  et al. 1994).
In our epidemiological study, M. tuberculosis isolates from Polish ТВ 
patients between 1993 and 1996 were typed by the RFLP method, using 
a probe for IS6110 and drug resistance profiles also were obtained ( S a j d u d a  
et al. 1998). One hundred isolates of M. tuberculosis analyzed were collected 
at the Department of Microbiology at the Institute of Tuberculosis and 
Lung Diseases in Warsaw, the remaining 85 isolates were obtained in 1996 
in the Hospital of Lung Diseases in Łódź. However, in some cases in which 
multiple isolates were from the same patient, each of the strains was 
identical by RFLP typing to the first isolate. Therefore, only 148 isolates 
from 148 patients were analyzed (Table 1). The species identification of the 
isolates was based on standard microbiologic tests. All the isolates were 
examined for their susceptibility to isoniazid, streptomycin, ethambutol and 
rifampin. The copy number of IS6110 in each of the isolates was determined 
from the number of bands hybridizing to the probe, and ranged from 
0 to 18. The DNA extracted from two isolates obtained from Polish 
patients did not hybridize with IS6110 DNA. Also by PCR with the 
INS1-INS2 primers (specific to the IS6110) no amplifiable IS6//0 DNA 
was found in these strains. Hybridization patterns consistent with M. 
tuberculosis with the IS/0S7 and DR-r probes (36 bp oligonucleotides 
flanking the IS6110 element) were demonstrated for both of these strains. 
The majority, 126 of the 148 investigated isolates (85%), contained between 
6 and 11 copies of IS6110. None of the strains carried only a single copy 
of the element. 91 different DNA fingerprint patterns were observed in the
96 isolates from Warsaw (the two isolates carrying no IS6110 element were 
excluded). Of the 91 patterns, only four were shared by two or three isolates, 
whereas the remaining 87 isolates (90,6% of isolates) gave unique fingerprint 
patterns. The relatively low level of clustering (9,4%) likely reflects the 
wide geographic area from which these strains were derived. In contrast, 
among 50 strains isolated in Łódź, only 38 different fingerprint 
patterns were revealed. Of these 38 RFLP types, nine were shared by two 
strains, and one was identical for four strains. The remaining 28 patterns were 
unique.
Table 1: Polymorphisms of M. tuberculosis isolates from 146 ТВ patients in Poland during 
1993-1996°
Year Unique strains No. of clusters
N o. of strains in 
RFLP cluster
Total
Institute of Tuberculosis and Lung Diseases, Warsaw
1993 5 1 2 7
1994 27 1 2 29
1995 55 1 2 60
1 3
Total 87 4 2-3 96
Hospital of Lung Diseases, Łódź
1996 28 9 2 50
1 4
Total 28 10 2-4 SO
“ Excluding two isolates carrying no IS6110 element.
IS6110 DNA fingerprints of 42 drug-resistant isolates were compared 
with those of 99 drug- sensitive isolates. The result showed no noticeable 
difference in banding pattern or copy number of IS6110 between drug-sensitive 
and drug-resistant isolates. Susceptible and resistant or even MDR (multidrug 
-resistant) strains were found in the same cluster.
Molecular techniques are used to track specific strains of pathogens and 
to determine more precisely the distribution of infectious diseases in 
populations, providing opportunities for more effective interventions. Currently, 
the most widely used genetic subtyping method for M. tuberculosis is 
restriction fragment length polymorphism (RFLP) analysis using the or-
ganism’s repetitive DNA element \S6iI0  ( v a n  S o o l i n g e n  et al. 1994). 
This method has been used to investigate outbreaks in health care settings 
and communities, to determine risk factors for active transmission of ТВ, 
to estimate the proportion of epidemiological links not identified by 
conventional contact tracing, to identify mis-diagnosis due to laboratory
cross-contamination and to quantify ТВ transmission between subpopulations. 
However, this RFLP typing method has several limitations. One major 
disadvantage is the time and labour required to perform the procedure. 
Moreover, strains with low (1-5) IS6110 copy numbers, frequently found 
in some part of the world, or devoid of the element cannot be adequately 
analysed by this method. In this context, alternative polymerase chain 
reaction (PCR)-based techniques, including double-repetitive-element PCR 
(DRE-PCR), seem particularly promising. The DRE-PCR is a rapid subtyping 
method based on PCR amplification of M. tuberculosis DNA segments 
located between two repetitive elements: IS6110 and the polymorphic 
GC-rich repetitive sequence, and it is recommended as a second-line test 
for analysis of M. tuberculosis isolates.
In this study we applied a standardized molecular strain typing method 
followed by DRE-PCR to characterize M. tuberculosis strains isolated from 
patients in Łódź area between 1996 and 2000 (D e l a  et al. in preparation). 
This analysis may provide a basis for estimating the relative importance, 
in this community, of recent transmission versus reactivation.
The isolates of M. tuberculosis analyzed in this study were collected in 
the Hospital of Lung Diseases in Łagiewniki, Łódź. This laboratory serves 
as a diagnostic service laboratory for the city and Łódź area. The isolates 
were randomly sampled from the beginning of 1996 to mid-2000. The 
species identification of the isolates was based on standard microbiological 
tests. All the isolates were examined for their susceptibility to ethambutol, 
isoniazid, streptomycin, and rifamipin with the BACTEC system. Only 
4 strains (1.6%) were observed to be resistant to isoniazid (INH).
The 250 M. tuberculosis strains were analyzed by the RFLP technique. 
The copy number of IS6110 in each of the strains ranged from 1 to 13. 
The majority, 212 of the 250 investigated strains (85%), contained between 
6 and 11 copies of IS6110. 12% of the isolates were found to be low-copy- 
number strains (carrying from one to five copies of the IS6110 element), 
including two strains harboring only a single copy of the insertion sequence.
In this study, 218 different IS6110 DNA fingerprint patterns were observed 
in the 250 strains analyzed. Of the 218 patterns, 20 were shared by from two 
to five strains, whereas the remaining 198 patterns were observed only once 
each in this investigation. Fifty-two strains were included in 20 cluster patterns. 
One cluster occurred in 5 strains, two clusters in 4 strains, five clusters in
3 strains, and 12 clusters in 2 strains (Fig. 5). Despite the great diversity of the 
patterns among the isolates, a computer-assisted similarity analysis demonstra-
ted a relatively high level of relatedness among a large number of different 
patterns. The majority of the patterns were included in several big clusters. The 
similarity among the individual non-identical patterns within each of these 














































































































































































Seventy-five isolates from 73 patients were subject to DRE-PCR analysis. 
The 21 of these were low-copy-number isolates, and the remaining 54 were 
high-copy-number isolates (carrying more than five copies of the IS6110 
element). No correlation was observed between copy number of IS6 //0 and 
number of DRE-PCR bands in the isolates tested. As with IS6110 RFLP 
analysis, two repetitive isolates from two patients were found identical also 
by DRE-PCR typing.
The agarose gel electrophoresis patterns generated by the DRE-PCR 
method were compared with the IS6//0-based RFLP patterns. The RFLP 
method yielded 218 distinct banding patterns among 263 isolates from 250 
patients. Twenty of these were cluster patterns that included 52 patients. 
The DRE-PCR method gave 48 different patterns among 75 isolates from 
73 patients selected for the analysis.
In contrast to previous study that focused on the RFLP analysis of 
randomly selected Polish M. tuberculosis isolates ( S a j d u d a  et al. 1998), 
the present study was aimed to establish a distribution of various RFLP 
types circulating in the community with one of the highest incidence of 
ТВ in Poland. Analysis by DNA fingerprinting of M. tuberculosis isolates 
in Łódź area showed a great heterogeneity of the RFLP patterns. The 
results suggest that endogenous reactivation was the major determinant of 
79.2% of the cases, which was the proportion of strains with unique RFLP 
patterns. The occurrence of 20 distinct clusters comprising 52 of the strains 
(20.8%) suggests that one fifth of the ТВ cases studied developed active 
disease from a recent exogenous transmission. However, this suggestion 
cannot be proved in majority of the cases because of inability to identify 
patient contacts within the strain clusters. In contrast to the standard 
I S 6110 RFLP procedure, DRE-PCR method is simpler and faster to 
perform and may not require a highly sophisticated laboratory setting.
We also analyzed by IS6110 restriction fragment length polymorphism 
(RFLP) and spoligotyping 141 drug-resitant M. tuberculosis strains obtained 
from Polish patients between 1999-2000 (our unpublished data). The 
generated IS6110 fingerprint patterns were highly variable. The number of 
IS6110 copies per isolate varied from 5 to 21. The majority, of the 139 
strains contained 6 to 11 IS6110 copies, with a mean of 9 bands.
One hundred twenty-three distinct IS6110 fingerprint patterns were 
observed in the 139 analyzed isolates (multiple isolates from one patient 
were excluded). Of these 123 patterns, 112 patterns were observed only 
once each in this investigation, whereas 11 were shared by two or more 
isolates. Some strains with identical IS6110 patterns were identified of the 
same family or patients living in the same area, indicating active transmission.
All the isolates were subjected to spoligotyping analysis and the results 
compared with those obtained by IS6770-associated RFLP. A total of 68
spoligotypes were identified in the 139 isolates. There were 9 spoligotypes 
identified among 27 isolates assigned to 11 IS6110 clusters. In addition, 
among 112 isolates with unique IS6110 profiles, 63 spoligotypes were identified.
3. Molecular mechanisms of drug resistance
Drug-resistant tuberculosis is becoming an increasing public health 
problem and poses a serious threat to the control of this disease. It is 
estimated that at least 50 million people is infected with drug-resistant 
tuberculosis. It is likely that this situation will get worse with the patter 
of increasing antibiotic use or misuse, the human immunodeficiency virus 
(HIV) pandemic, and poor tuberculosis control programs. A great deal of 
progress has been made in understanding the molecular basis of drug 
resistance in M. tuberculosis in the past few years. Resistance mechanisms 
to all five of the first-line tuberculosis drugs, isoniazid (1NH), rifampin 
(RMP), pyrazinamide (PZA), ethambutol (EMB), and streptomycin (SM), 
are already known. Bacteria use a number of strategies to achieve drug 
resistance. These can be roughly summarized in four categories: barrier 
mechanisms (decreased permeability and efflux pumps), degrading or inac-
tivating enzymes (e.g. Д-lactamases), modification of pathways involved in 
drug activation or metabolism (e.g. katG and INH resistance, pacA and 
PZA resistance), and drug target modification (e.g. rpoB and RMP resistance) 
ora target amplification (e.g. inhA and INH resistance). While plasmids or 
transposons have been shown to mediate drug resisance in various bacterial 
species including the fast-growing Mycobacterium fortuitum, these mobile 
genetic elements have not heen found to cause drug resistance in 
M. tuberculosis. Instead, drug resistance in M. tuberculosis is caused by 
mutations in chromosomal genes. The multidrug-resistant (MDR) phenotype 
is caused by sequential accumulation of mutations in different genes 
involved in individual drug resistance due to inappropriate treatment or 
poor adherence to treatment. Mechanisms of resistance to tuberculosis-specific 
drugs such as INH, PZA and ethambutol (EMB) are unique to M. tuberculosis 
or mycobacteria. A highly hydrophobic cell envelope acting as an effective 
permeability barrier to many compounds characterizes mycobacteria.
Isoniazid (isonicotinic acid hydrazide, INH) is an important first-line 
tuberculosis drug. INH is a prodrug that requires the activation of bacterial 
catalase-proroxidase enzyme (Kat G) to generate a range of reactive (both 
reactive oxygen and reactive organic) radicals, which then attack multiple 
targets in the tubercle bacillus ( Z h a n g  et al. 1992). The best known target 
is the cell wall synthesis pathway, where at least two enzymes, InhA (enoyl
acyl carrier protein (ACP) inductase), ( B a n e r j e e  et al. 1994) and KasA 
(beta-ketoacyl ACP synthase), (M d lU L I  et al. 1998), have been identified 
as targets for INH inhibition. It is important to note that INH has 
multiple effects on the tubercle bacillus, and it is not always easy to 
pinpoint which is the most essential target, whose inhibition will lead to 
cell death. During INH activation, the various reactive organic and reac-
tive oxygen radicals produced could cause damage to various cellular 
targets, including DNA, carbohydrates, and lipids. In addition, INH has 
been proposed to affect NAD metabolism by incorporating into NAD 
through exchange with nicotinamide or by activating NAD glycohydrolase 
by removing its repressor, leading to NAD depletion ( B e k i e r k u n s t  et al. 
1966).
Soon after INH was introduced in clinical treatment of tuberculosis, it 
was found that clinical isolates frequently lost catalase and peroxidase 
enzyme activities upon development of INH resistance. I his observation 
led to the cloning of the catalase-peroxidase gene (katG) and identification 
of katG mutations (or deletion of the katG) as the cause for INH 
resistance. Subsequent studies have shown that katG point mutation is 
more frequent than deletions in INH-resistant strains. Mutation in KatG 
reduce its ability to activate the prodrug INH, thus leading to resistance. 
The katG gene is situated in a highly variable region of the genome 
containing repeat DNA sequences, which may be the cause for the instability 
of this region and in turn may contribute to the frequency of katG 
mutations in INH-resistant strains.
A reactive form of INH inhibits InhA by reacting with NAD(H) 
cofactor bound to the enzyme active site, forming a covalent adducts 
(isonicotinic acyl NADH) that is apt to bind with high affinity (ROZW ARSKl 
et al. 1998). Resistance to INH can occur by mutations at the enzyme’s 
active site that lower the enzyme’s affinity for NADH without affecting 
the enzymatic activity or by increased expression of InhA ( B a s s o  et al.
1998). In general mutations in inhA are associated with a low level of INH 
resistance. In contrast, mutations in katG can cause either a low or high 
level of resistance, depending on the effect of mutations on the catalase- 
peroxidase enzyme activity required for INH activation. Mutations leading 
to complete loss of enzyme activity usually cause high level INH resistance. 
Mutations in InhA not only cause INH resistance but also confer resistance 
to the structurally related second-line antitubereulosis drug -  ethionamide. 
Mutations in kasA have so far been found in INH resistant as well as in 
INH susceptible strains ( M d l u l i  et al. 1998). In most INH resistant 
isolates presenting kasA mutations, additional mutations have been identified 
in katG or inhA. Thus the biological significance of kas A  mutations needs 
careful definition.
Rifampin (RMP) is a broad-spectrum antimicrobial agent, which diffuses 
rapidly across the hydrophobic cell envelope. RMP interferes with synthesis 
of mRNA by binding to the bacterial DNA-dependent RNA polymerase. 
All bacteria (including mycobacteria) achieve resistance to RMP by a com-
mon strategy, mutation in a defined region of the RNA polymerase 
subunit ß (RpoB). In the 81-bp core region of the RNA polymerase 
ß  subunit gene, mutations are observed with high frequency (H ON O R E, 
Co l e  1993) (Fig. 6).
530 912
rpoB
Fig. 6. D NA  targets for rifampin and streptomycin. The most frequently mutated regions are 
indicated by arrows. See details in the text
Streptomycin (SM) inhibits initiation of mRNA translation and facili-
tates misreading of the genetic code and inefficient proofreading by the 
ribosome. The site of action is in the small 30S subunit of the ribosome, 
specifically at ribosomal protein S12 and 16S rRNA.
M. tuberculosis becomes resistant by mutating the target of SM in the 
ribosomes The principal site of mutation is the rpsL gene, encoding 
ribosomal protein S12 ( F i n k e n  et al. 1993; S r e e v a t s a n  et al. 1996). 
A second mechanism of resistance in M. tuberculosis is rrs (Fig. 6). While 
most bacteria have multiple copies of rrs, M. tuberculosis and other 
slow-growing mycobacteria are characterized by a single copy of rrs 
( B o t t g e r  1994). Thus the loops of 16S rRNA that interacts with the SI2 
protein constitute an easily selected mutation site. Such mutations are 
clustered in the highly conserved 530 loop and on the adjacent 915 region 
( F in k e n  et al. 1993). A third mechanism accounting for low-level resistance 
remains unidentified, but it has been suggested that it is derived from
Understanding the mechanisms of drug-resistance has practical application 
for rapid detection of drug-resistant tuberculosis by molecular methods. 
Genotypic analysis involves amplification by PCR of the genomic region 
conferring resistance, followed by postamplification analysis of mutations.
Recently, a world wide increase in the incidence of drug-resistant strains 
of M. tuberculosis was observed, especially multidrug-resistant (MDR-TB) 
isolates resistant to at least isoniazid and rifampin. The incidence of ТВ 
in Poland and also drug resistance is lower compared to the international 
data, but the importation of drug-resistant strains from former Soviet 
Union is possible. This situation need to develop faster and more accurate 
methods for detection of resistance to antituberculosis drugs (INH, RMP, 
SM). We have recently examined the molecular basis of drug resistance of 
M. tuberculosis strains isolated in Poland. The primary drug resistance of 
Mycobacterium tuberculosis in our country increased two-fold between 1997 
and 2000. Among 3705 drug-resistant strains investigated in 2000, 169 were 
resistant to streptomycin alone or in combination with isoniazid, rifampin 
and/or ethambutol. The molecular basis of streptomycin resistance for 88 
(52%) of these strains in comparison with 15 susceptible controls was 
determined. The most prevalent mutation was the single substitution 
Lys43Arg in the rpsL gene found in 30.7% of the strains analyzed. 
However, as many as 51% of the investigated strains did not carry any 
mutation in the rpsL or rrs genes.
We also tested a total of 105 rifamipin (RMP) and/or isoniazid (INH)- 
resistant strains of Mycobacterium tuberculosis for mutations associated with 
resistance to RMP and INH by sequence analysis. Three loci associated 
with drug-resistance were selected for characterization: rpoB (RMP), IcatG 
and the regulatory region of inhA (INH). The most common point mutations 
were in codons 531 (41%), 516 (16%), and 526 (9%) of the rpoB gene. 
Mutations were not found in 2 (3%) of the isolates. In the case of 
resistance to INH, six different mutations in the katG gene of 83 resistant 
strains were detected. Fifty-seven (69%) isolates exhibited nucleotide sub-
stitutions at codon 315. One strain harbored a mutation affecting codon 
279 (Gly279Thr). Twelve of 26 INH-resistant strains with the wild-type 
codon 315 (14.5% of all strains tested) had mutation -  15C—>T in the 
regulatory region of inhA. The detailed data of drug resistance analysis of 
MDR strains isolated in Poland will be published soon.
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